This post was originally published on this site.
Strategy (Nasdaq: MSTR) heads into MSCI’s final November review list on Nov. 11 with its index seat on the line, and analysts are already gaming out what a removal could cost. The Countdown to MSCI’s Verdict The index provider finalized new rules on Oct. 15 that make “non-operating companies” ineligible for its Global Investable Market […]
